Cortancyl



Indications and Reactions:

Role Indications Reactions
Primary
B-cell Lymphoma 48.7%
Drug Use For Unknown Indication 13.2%
Product Used For Unknown Indication 13.2%
Asthma 7.9%
Breast Cancer 2.6%
Cryptogenic Organising Pneumonia 2.6%
Prophylaxis Against Gastrointestinal Ulcer 2.6%
Rheumatoid Arthritis 2.6%
Atrial Fibrillation 1.3%
Chronic Kidney Disease 1.3%
Deep Vein Thrombosis 1.3%
Hiatus Hernia 1.3%
Hypertension 1.3%
Pulmonary Embolism 22.2%
Acute Respiratory Distress Syndrome 11.1%
Bronchial Disorder 11.1%
International Normalised Ratio Increased 11.1%
Lung Adenocarcinoma 11.1%
Nausea 11.1%
Pulmonary Alveolar Haemorrhage 11.1%
Thrombocytopenia 11.1%
Secondary
Rheumatoid Arthritis 24.8%
Drug Use For Unknown Indication 17.9%
Product Used For Unknown Indication 15.6%
Renal Transplant 7.5%
B-cell Lymphoma 6.7%
Behcet's Syndrome 4.0%
Hypertension 3.8%
Acute Lymphocytic Leukaemia 2.6%
Ankylosing Spondylitis 2.0%
Non-hodgkin's Lymphoma 1.8%
Prophylaxis 1.7%
Hiv Infection 1.5%
Crohn's Disease 1.4%
Prostate Cancer 1.4%
Osteoporosis 1.3%
Psoriatic Arthropathy 1.3%
Systemic Lupus Erythematosus 1.3%
Diabetes Mellitus 1.3%
Prophylaxis Against Transplant Rejection 1.2%
Liver Transplant 1.0%
Vomiting 10.2%
Osteonecrosis 9.6%
Pyrexia 7.1%
Squamous Cell Carcinoma 6.6%
Thrombocytopenia 6.0%
Tuberculosis 5.2%
Progressive Multifocal Leukoencephalopathy 4.9%
Sepsis 4.7%
Weight Decreased 4.7%
Renal Failure Acute 4.4%
Transplant Rejection 4.4%
Urinary Tract Infection 4.1%
Interstitial Lung Disease 3.8%
Neutropenia 3.8%
Leukocytosis 3.6%
Neuropathy Peripheral 3.6%
Diabetes Mellitus 3.3%
Lung Adenocarcinoma Stage I 3.3%
Pruritus 3.3%
Septic Shock 3.3%
Concomitant
Rheumatoid Arthritis 32.6%
Drug Use For Unknown Indication 19.1%
Product Used For Unknown Indication 16.2%
Hypertension 3.9%
Renal Transplant 3.9%
Prophylaxis 3.1%
Osteoporosis 3.0%
Pain 2.7%
Crohn's Disease 2.2%
Depression 1.7%
Immunosuppression 1.5%
Ankylosing Spondylitis 1.5%
Prophylaxis Against Transplant Rejection 1.5%
Hiv Infection 1.3%
Anxiety 1.1%
Diabetes Mellitus 1.0%
Lymphoma 1.0%
Systemic Lupus Erythematosus 0.9%
Asthma 0.9%
Non-small Cell Lung Cancer 0.8%
Thrombocytopenia 11.7%
Vomiting 9.9%
Pyrexia 8.1%
Renal Failure Acute 6.8%
Renal Failure 6.0%
Weight Decreased 5.6%
Neutropenia 4.9%
Cytolytic Hepatitis 4.4%
Sepsis 4.2%
Weight Increased 4.2%
Rheumatoid Arthritis 4.1%
Tachycardia 4.0%
Toxic Skin Eruption 4.0%
Sinusitis 3.6%
Urinary Tract Infection 3.4%
Tooth Extraction 3.2%
Pancytopenia 3.1%
Tooth Infection 3.0%
Transaminases Increased 3.0%
Rash Maculo-papular 2.8%
Interacting
Drug Use For Unknown Indication 19.7%
Prophylaxis Against Transplant Rejection 8.5%
Renal Transplant 8.5%
Spinal Compression Fracture 8.5%
Depression 5.6%
Nephrotic Syndrome 5.6%
Prophylaxis 5.6%
Atrial Fibrillation 4.2%
Oesophageal Candidiasis 4.2%
Aspergillosis 2.8%
Atrial Flutter 2.8%
Bronchitis 2.8%
Essential Hypertension 2.8%
Helicobacter Infection 2.8%
Hypercholesterolaemia 2.8%
Hypertension 2.8%
Immune Thrombocytopenic Purpura 2.8%
Optic Neuritis 2.8%
Organ Transplant 2.8%
Erysipelas 1.4%
International Normalised Ratio Increased 15.8%
Drug Interaction 10.5%
Hyponatraemia 10.5%
Renal Failure Acute 10.5%
Malaise 5.3%
Melaena 5.3%
Meningorrhagia 5.3%
Presyncope 5.3%
Pulmonary Embolism 5.3%
Rectal Haemorrhage 5.3%
Renal Haemorrhage 5.3%
Transplant Rejection 5.3%
Urticaria 5.3%
Vomiting 5.3%